Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours

Saved in:
Bibliographic Details
Published in:European journal of nuclear medicine and molecular imaging 2005-04, Vol.32 (4), p.511-512
Main Authors: Forrer, F, Mueller-Brand, J, Maecke, H
Format: Article
Language:English
Subjects:
Body Burden
Female
Humans
Male
Metabolic Clearance Rate
Middle Aged
Neuroendocrine Tumors - diagnostic imaging
Neuroendocrine Tumors - metabolism
Neuroendocrine Tumors - radiotherapy
Octreotide - analogs & derivatives
Octreotide - pharmacokinetics
Octreotide - therapeutic use
Organ Specificity
Radiation Injuries - prevention & control
Radiation Protection - methods
Radiometry - methods
Radionuclide Imaging
Radiopharmaceuticals - pharmacokinetics
Radiopharmaceuticals - therapeutic use
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted - methods
Relative Biological Effectiveness
Risk Assessment - methods
Risk Factors
Somatostatin - analogs & derivatives
Somatostatin - pharmacokinetics
Somatostatin - therapeutic use
Tissue Distribution
Yttrium Radioisotopes - pharmacokinetics
Yttrium Radioisotopes - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1619-7070
1619-7089
DOI:10.1007/s00259-004-1726-3